查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1663503

血管内治疗设备市场，按产品、按程序、按最终用户、按国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Endovascular Treatment Devices Market, By Product, By Procedure, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 316 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年血管内治疗设备市场规模价值为 34.5033 亿美元，2025 年至 2032 年期间的复合年增长率为 9.50%。

血管内治疗设备市场-市场动态

血管疾病盛行率不断上升

由于人口老化、久坐的生活方式以及肥胖、高血压和糖尿病等风险因素，血管疾病（包括週边动脉疾病 (PAD)、主动脉瘤和静脉血栓栓塞症 (VTE)）变得越来越普遍。根据世界卫生组织（WHO）的数据，心血管疾病（包括血管疾病）每年导致近1,790万人死亡，占全球死亡人数的32%。越来越多的患者需要有效的干预来恢復血流并预防危及生命的併发症，从而增加了对先进治疗方案的需求。血管内设备，例如支架移植物、球囊导管和血栓切除系统，为治疗这些疾病提供了微创解决方案。它们比传统的开放式手术更安全、更有效，减少了住院时间、恢復时间和术后併发症的风险。此外，政府改善医疗保健基础设施和提高人们对血管疾病早期诊断和治疗认识的措施进一步支持了市场扩张。例如，旨在降低心血管风险的国家健康运动和现代血管护理技术的整合正在促进成长。

血管内治疗设备市场-关键见解

  • 根据我们的研究分析师的分析，预测期内（2025-2032 年），全球市场预计年复合成长率约为 9.50%
  • 根据产品细分，预计支架将在 2024 年占据最大市场份额
  • 根据最终用户细分，医院是 2024 年的主要细分市场
  • 从地区来看，北美是 2024 年最大的收入来源

血管内治疗设备市场-細項分析：

全球血管内治疗设备市场根据产品、程序、最终用户和地区进行细分。

根据产品，市场分为三类：支架、球囊导管和下腔静脉过滤器。支架因其广泛用于治疗动脉阻塞，有效恢復血流并降低再狭窄风险而占据市场主导地位。此外，药物洗脱和生物可吸收支架的进步提高了长期效果，推动了它们继续保持市场领先地位。

根据最终用户，市场分为三类：医院、门诊手术中心、专科诊所。医院主导市场，因为它们配备了先进的医疗基础设施、专门的血管护理单元以及复杂血管内手术所需的熟练专业人员。此外，更高的患者流量和术后护理设施的可用性使医院成为血管治疗的首选。

血管内治疗设备市场-地理洞察

北美引领全球市场，这得益于血管疾病的高发性、先进的医疗保健系统以及微创手术的广泛应用。据美国心臟协会称，心血管疾病仍然是美国的主要死亡原因，这进一步推动了对创新血管内解决方案的需求。此外，优惠的报销政策和持续的产品进步增强了该地区的主导地位。由于人口老化、医疗支出增加以及政府推动心血管疾病管理的倡议，欧洲占据了相当大的市场份额。德国、英国和法国等国家凭藉其强大的医疗保健体系和医疗设备的技术进步做出了巨大贡献。预计亚太地区将出现最快的成长，这得益于医疗保健意识的提高、週边动脉疾病病例的增加以及医疗保健基础设施的改善。中国、印度和日本等国家快速的城市化、生活方式的改变以及老龄人口的成长进一步促进了市场的扩张。此外，政府对现代医疗设施的投资和日益增多的医疗机会正在推动该地区的需求。

血管内治疗设备市场-竞争格局：

血管内治疗设备市场的竞争格局特征是主要参与者之间的激烈竞争，重点在于创新、产品差异化和策略合作。各公司正大力投资研发，以推出安全性、有效性和耐用性更高的下一代设备，例如药物洗脱和生物可吸收支架、先进的栓塞保护系统和新型血栓切除设备。市场参与者也在扩大其产品组合，以满足针对不同血管疾病的微创解决方案日益增长的需求。策略伙伴关係、合併和收购是增强市场影响力、推动技术进步和扩大地理覆盖范围的常用策略。此外，参与者正在强调监管部门的批准和临床试验以获得竞争优势，同时满足严格的安全标准并确保遵守全球医疗保健法规。人工智慧诊断和智慧血管内技术的日益普及正在塑造市场，为提高精准度和个人化治疗创造机会。有竞争力的价格、强大的分销网络和售后支援对于保持市场份额也发挥关键作用。随着对先进血管治疗解决方案的需求不断增长，竞争强度预计也会上升，从而促进这一充满活力的领域的持续创新和患者治疗效果的改善。

最新动态：

  • 2024 年 6 月，波士顿科学公司宣布达成协议，收购 Silk Road Medical, Inc.，该公司专门生产颈动脉血管重建 (TCAR) 设备，这是一种旨在预防颈动脉疾病患者中风的微创手术。
  • 2024 年 7 月，Sensome 与日本 Cosmotec 签署了其血凝感应导丝的独家经销协议。此次合作使 Cosmotec 能够将 Sensome 的创新技术商业化，该技术旨在在血管内手术期间即时检测血栓，改善临床决策和患者预后。该协议标誌着 Sensome 向日本市场扩张迈出了重要一步，增强了其尖端医疗设备的获取管道。
  • 2024年11月，Solaris Endovascular, Inc. 在美国成立，致力于开发末期肾臟病和周边动脉疾病治疗的透析解决方案。其旗舰产品 Solaris SX 血管支架移植物旨在利用先进的技术减少再狭窄并提高通畅率。

目录

第 1 章：血管内治疗设备市场概述

  • 研究范围
  • 市场估计年限

第 2 章：执行摘要

  • 市场片段
    • 血管内治疗设备市场（按产品）
    • 血管内治疗设备市场片段（依程序）
    • 血管内治疗设备市场片段（按最终用户）
    • 血管内治疗设备市场（按国家/地区）
    • 血管内治疗设备市场片段（按地区）
  • 竞争洞察

第 3 章：血管内治疗设备关键市场趋势

  • 血管内治疗设备市场驱动因素
    • 市场驱动因素的影响分析
  • 血管内治疗设备市场限制
    • 市场限制的影响分析
  • 血管内治疗设备的市场机会
  • 血管内治疗设备市场未来趋势

第 4 章：血管内治疗设备产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景规划
  • 规范架构分析

第五章：血管内治疗设备市场：地缘政治张力升级的影响

  • 新冠肺炎疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第 6 章：血管内治疗设备市场格局

  • 2024 年血管内治疗设备市占分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第 7 章：血管内治疗设备市场 - 按产品分类

  • 概述
    • 按产品细分的份额分析
    • 支架
    • 球囊导管
    • 下腔静脉过滤器
    • 其他的

第 8 章：血管内治疗设备市场 - 按程序

  • 概述
    • 按程序进行细分份额分析
    • 血管成形术
    • 动脉瘤修復
    • 血栓切除术
    • 其他的

第 9 章：血管内治疗设备市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 门诊手术中心
    • 专科诊所
    • 其他的

第 10 章：血管内治疗设备市场 - 按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美血管内治疗设备主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（按产品划分）
    • 北美市场规模和预测，按程序
    • 北美市场规模及预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲血管内治疗设备主要製造商
    • 欧洲市场规模及预测（按国家）
    • 欧洲市场规模及预测（依产品划分）
    • 欧洲市场规模和预测，按程序
    • 欧洲市场规模及预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区血管内治疗设备主要製造商
    • 亚太地区市场规模及预测（依国家/地区划分）
    • 亚太地区市场规模及预测（依产品划分）
    • 亚太地区市场规模及预测（依流程划分）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲血管内治疗设备主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按产品划分）
    • 拉丁美洲市场规模及预测（依流程划分）
    • 拉丁美洲市场规模及预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲 (MEA)
    • 概述
    • 中东和非洲的血管内治疗设备主要製造商
    • MEA 市场规模及预测（依国家/地区划分）
    • MEA 市场规模及预测（依产品划分）
    • MEA 市场规模和预测（按程序）
    • MEA 市场规模及预测（依最终用户）
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其他地区

第 11 章：主要供应商分析-血管内治疗设备产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Boston Scientific Corporation
    • Medtronic plc
    • Abbott Laboratories
    • Johnson & Johnson Services, Inc.
    • Terumo Corporation
    • Cook Group Incorporated
    • Edwards Lifesciences Corporation
    • WL Gore & Associates, Inc.
    • Philips Healthcare
    • Siemens Healthineers
    • Cardinal Health
    • Stryker Corporation
    • Baxter International Inc.
    • Asahi Intecc Co., Ltd.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4673

REPORT HIGHLIGHT

Endovascular Treatment Devices Market size was valued at US$ 3,450.33 Million in 2024, expanding at a CAGR of 9.50% from 2025 to 2032.

Endovascular treatment devices are medical instruments used in minimally invasive procedures to treat various vascular diseases by accessing blood vessels through small incisions or punctures. These devices include stents, balloon catheters, embolic protection devices, and thrombectomy systems, which are essential for managing conditions like aneurysms, arterial blockages, and venous thromboembolism. Unlike traditional open surgeries, endovascular treatments offer a less invasive alternative, reducing patient trauma, hospital stays, and recovery times. The need for endovascular treatment devices arises from the growing prevalence of cardiovascular and peripheral vascular diseases driven by aging populations, sedentary lifestyles, and increasing rates of obesity and diabetes. These devices enable precision-targeted interventions, improving clinical outcomes and patient safety. For example, stent grafts reinforce weakened blood vessels, preventing potentially fatal ruptures, while thrombectomy devices remove life-threatening blood clots with minimal risk. Their importance lies in transforming the management of complex vascular conditions. Endovascular procedures significantly reduce morbidity and mortality rates compared to conventional surgeries. They also lower healthcare costs by minimizing postoperative complications and facilitating faster recovery. Furthermore, technological advancements in device design and materials continue to enhance the effectiveness and durability of treatments, driving the adoption of endovascular solutions as a cornerstone in modern vascular care.

Endovascular Treatment Devices Market- Market Dynamics

Increasing prevalence of vascular diseases

Vascular conditions, including peripheral artery disease (PAD), aortic aneurysms, and venous thromboembolism (VTE), are becoming more widespread due to aging populations, sedentary lifestyles, and risk factors such as obesity, hypertension, and diabetes. According to the World Health Organization (WHO), cardiovascular diseases, which include vascular disorders, account for nearly 17.9 million deaths annually, representing 32% of all global deaths. A growing number of patients require effective interventions to restore blood flow and prevent life-threatening complications, increasing the demand for advanced treatment options. Endovascular devices, such as stent grafts, balloon catheters, and thrombectomy systems, offer minimally invasive solutions to manage these conditions. They provide a safer and more efficient alternative to traditional open surgeries, reducing hospital stays, recovery times, and the risk of postoperative complications. Furthermore, government initiatives to improve healthcare infrastructure and raise awareness about early diagnosis and treatment of vascular diseases further support market expansion. For example, national health campaigns targeting cardiovascular risk reduction and the integration of modern vascular care technologies are fostering growth.

Endovascular Treatment Devices Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.50% over the forecast period (2025-2032)
  • Based on Product segmentation, Stents was predicted to show maximum market share in the year 2024
  • Based on End-User segmentation, Hospitals was the leading segment in 2024
  • On the basis of region, North America was the leading revenue generator in 2024

Endovascular Treatment Devices Market- Segmentation Analysis:

The Global Endovascular Treatment Devices Market is segmented on the basis of Product, Procedure, End-User and Region.

The market is divided into three categories based on Product: Stents, Balloon Catheters and Inferior Vena Cava Filters. Stents dominate the market due to their widespread use in treating arterial blockages by restoring blood flow efficiently and reducing the risk of restenosis. Additionally, advancements in drug-eluting and bioresorbable stents enhance long-term outcomes, driving their continued market leadership.

The market is divided into three categories based on End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics. Hospitals dominate the market because they are equipped with advanced medical infrastructure, specialized vascular care units, and skilled professionals required for complex endovascular procedures. Additionally, the higher patient inflow and availability of post-operative care facilities make hospitals the preferred choice for vascular treatments.

Endovascular Treatment Devices Market- Geographical Insights

North America leads the global market, driven by a high incidence of vascular diseases, advanced healthcare systems, and widespread adoption of minimally invasive procedures. According to the American Heart Association, cardiovascular diseases remain a leading cause of death in the United States, further boosting the demand for innovative endovascular solutions. Additionally, favorable reimbursement policies and continuous product advancements strengthen the region's dominance. Europe holds a substantial market share, supported by an aging population, increased healthcare spending, and government initiatives promoting cardiovascular disease management. Countries like Germany, the United Kingdom, and France contribute significantly due to their robust healthcare systems and technological advancements in medical devices. The Asia-Pacific region is expected to witness the fastest growth, driven by rising healthcare awareness, increasing cases of peripheral artery diseases, and improvements in healthcare infrastructure. Rapid urbanization, lifestyle changes, and a growing elderly population in countries like China, India, and Japan further contribute to market expansion. Moreover, government investments in modern healthcare facilities and increasing access to medical treatments are propelling demand in this region.

Endovascular Treatment Devices Market- Competitive Landscape:

The competitive landscape of the endovascular treatment devices market is characterized by intense rivalry among key players focusing on innovation, product differentiation, and strategic collaborations. Companies are investing heavily in research and development to introduce next-generation devices with improved safety, efficacy, and durability, such as drug-eluting and bioresorbable stents, advanced embolic protection systems, and novel thrombectomy devices. Market participants are also expanding their portfolios to cater to the growing demand for minimally invasive solutions across diverse vascular conditions. Strategic partnerships, mergers, and acquisitions are common tactics to enhance market presence, drive technological advancements, and expand geographic reach. Additionally, players are emphasizing regulatory approvals and clinical trials to gain a competitive edge while meeting stringent safety standards and ensuring compliance with global healthcare regulations. The increasing adoption of AI-driven diagnostics and smart endovascular technologies is shaping the market, creating opportunities for enhanced precision and personalized treatment. Competitive pricing, robust distribution networks, and post-sales support also play critical roles in maintaining market share. As the demand for advanced vascular treatment solutions grows, the competitive intensity is expected to rise, fostering continuous innovation and improved patient outcomes in this dynamic sector.

Recent Developments:

  • In June 2024, Boston Scientific announced an agreement to acquire Silk Road Medical, Inc., a company specializing in devices for transcarotid artery revascularization (TCAR), a minimally invasive procedure aimed at preventing strokes in patients with carotid artery disease.
  • In July 2024, Sensome signed an exclusive distribution agreement with Cosmotec in Japan for its clot-sensing guidewire. This partnership allows Cosmotec to commercialize Sensome's innovative technology, which is designed to detect blood clots in real time during endovascular procedures, improving clinical decision-making and patient outcomes. The agreement marks an important step in Sensome's expansion into the Japanese market, enhancing access to its cutting-edge medical devices.
  • In November 2024, Solaris Endovascular, Inc. has launched in the U.S. to develop solutions for dialysis access in end-stage kidney disease and peripheral artery disease treatment. Its flagship product, the Solaris SX vascular stent graft, aims to reduce restenosis and improve patency with advanced technology.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Boston Scientific Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Johnson & Johnson Services, Inc.
  • Terumo Corporation
  • Cook Group Incorporated
  • Edwards Lifesciences Corporation
  • W. L. Gore & Associates, Inc.
  • Philips Healthcare
  • Siemens Healthineers
  • Cardinal Health
  • Stryker Corporation
  • Baxter International Inc.
  • Asahi Intecc Co., Ltd.
  • Others

GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Stents
  • Balloon Catheters
  • Inferior Vena Cava Filters
  • Others

GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET, BY PROCEDURE - MARKET ANALYSIS, 2019 - 2032

  • Angioplasty
  • Aneurysm Repair
  • Thrombectomy
  • Others

GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others

GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Endovascular Treatment Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Endovascular Treatment Devices Market Snippet by Product
    • 2.1.2. Endovascular Treatment Devices Market Snippet by Procedure
    • 2.1.3. Endovascular Treatment Devices Market Snippet by End-User
    • 2.1.4. Endovascular Treatment Devices Market Snippet by Country
    • 2.1.5. Endovascular Treatment Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Endovascular Treatment Devices Key Market Trends

  • 3.1. Endovascular Treatment Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Endovascular Treatment Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Endovascular Treatment Devices Market Opportunities
  • 3.4. Endovascular Treatment Devices Market Future Trends

4. Endovascular Treatment Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Endovascular Treatment Devices Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Endovascular Treatment Devices Market Landscape

  • 6.1. Endovascular Treatment Devices Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Endovascular Treatment Devices Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Stents
    • 7.1.3. Balloon Catheters
    • 7.1.4. Inferior Vena Cava Filters
    • 7.1.5. Others

8. Endovascular Treatment Devices Market - By Procedure

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Procedure, 2024 & 2032 (%)
    • 8.1.2. Angioplasty
    • 8.1.3. Aneurysm Repair
    • 8.1.4. Thrombectomy
    • 8.1.5. Others

9. Endovascular Treatment Devices Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Ambulatory Surgical Centers
    • 9.1.4. Specialty Clinics
    • 9.1.5. Others

10. Endovascular Treatment Devices Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Endovascular Treatment Devices Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Endovascular Treatment Devices Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Endovascular Treatment Devices Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Endovascular Treatment Devices Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Endovascular Treatment Devices Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Endovascular Treatment Devices Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Boston Scientific Corporation
    • 11.2.2. Medtronic plc
    • 11.2.3. Abbott Laboratories
    • 11.2.4. Johnson & Johnson Services, Inc.
    • 11.2.5. Terumo Corporation
    • 11.2.6. Cook Group Incorporated
    • 11.2.7. Edwards Lifesciences Corporation
    • 11.2.8. W. L. Gore & Associates, Inc.
    • 11.2.9. Philips Healthcare
    • 11.2.10. Siemens Healthineers
    • 11.2.11. Cardinal Health
    • 11.2.12. Stryker Corporation
    • 11.2.13. Baxter International Inc.
    • 11.2.14. Asahi Intecc Co., Ltd.
    • 11.2.15. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us